Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

Quality Issues Redux

As we get ready to begin the New Year, let's hope some quality resolutions are made.
Dec 2, 2010

As we get ready to begin the New Year, let's hope some quality resolutions are made.

Riding the Employment Roller Coaster

2010 came with pay raises for those still employed and anxiety for all. This article contains bonus online material.
Dec 2, 2010

2010 came with pay raises for those still employed and anxiety for all. This article contains bonus online material.

Automated Inspection of Pharmaceutical Products

A conversation with Mike de la Montaigne, president of Eisai Machinery, USA Inc., about the possibilities for conducting fully automated product inspections.
Nov 2, 2010

A conversation with Mike de la Montaigne, president of Eisai Machinery, USA Inc., about the possibilities for conducting fully automated product inspections.

Novartis's Influenza Vaccine Program: A conversation with Matthew Stober, global head of technical operations for Novartis

Oct 2, 2010

Novartis' Matthew Stober discusses vaccine manufacturing, including egg- and cell-based systems.

Vaccine Manufacturing Reborn

Drugmakers hatch new manufacturing paradigms in the wake of the 2009 H1N1 influenza pandemic.
Oct 2, 2010

Drugmakers hatch new manufacturing paradigms in the wake of the 2009 H1N1 influenza pandemic.

This Again?

The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.
Oct 2, 2010

The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.

Survey Says...

New data provide insight into pharma-industry professionals' daily lives.
Sep 2, 2010

New data provide insight into pharma-industry professionals' daily lives.

An Ounce of Prevention

Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.
Aug 2, 2010

Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.

It takes a World

With more hands in the manufacturing pot, a good contingency plan is crucial to success.
Aug 1, 2010

With more hands in the manufacturing pot, a good contingency plan is crucial to success.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here